comprehensive -WSS

comprehensive

author：Wikipedia 2025-10-02 13:13:50 - browse：29481

Outgoing Bristol CEO Giovanni Caforio Emilie Pickering for STAT

It’s changing of the guard time at pharmaceutical giant Bristol Myers Squibb. On Wednesday, CEO Giovanni Caforio will step down. He’ll be replaced by Christopher Boerner, who is currently chief operating officer.

When Caforio took over in May 2015, Bristol was known as a big pharmaceutical firm with the high-flying stock of a biotechnology company, largely due to its role as the company that brought cancer immunotherapy to market. But Bristol stumbled in 2016 when its immunotherapy Opdivo failed to help patients with non-small cell cancer more than chemotherapy. Opdivo remained a big seller, but its failure allowed Merck’s rival Keytruda to move into position to become the best-selling medicine in the world. In 2019, Caforio tried to flip the script, buying the biotech Celgene for $74 billion.

STAT recently sat down with Caforio, 59, to look back on what went wrong and right with his tenure. He also reflected on what it meant to be a physician — and the son of a physician. “We were speaking about patient stories over lunch and dinner, when I was a kid, and I think that drove my passion for medicine,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： 2023 STAT Wunderkinds: get to know the winners

WSS

FDA warns J&J's Abiomed: We will regulate your software

Moderna hits safety problems in bold bid to reinvent medicine

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

'The Exorcist' director William Friedkin dead at 87

Mississippi candidates for statewide offices square off in party primaries

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

focus

comprehensive

entertainment

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

Drug repurposing or repositioning? The language matters

Medicare reduced heart disease by changing how it pays doctors

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

Virginia high school admissions case could be legal follow

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

BioMarin wins approval for gene therapy to treat hemophilia A

Why health workers in Gaza are injured or die at high rates

focus

STAT Summit: Biotech founders on deal

UnitedHealth’s board chair also owns a personal investment firm

'The Exorcist' director William Friedkin dead at 87

Appeals court upholds Josh Duggar's conviction for downloading child sex abuse images

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

focus

leisure time

explore

Wikipedia